Advancements in base business are helping quell fears of what will happen in a Covid trough.
Pfizer 's work on new products will help the company maintain its Covid momentum even as vaccine becomes a smaller business element, Goldman Sachs said Tuesday. Analyst Chris Shibutani upgraded the stock to buy from neutral with a price target of $60, which reflects a 15% upside over Monday's close. His previous price target of $47 indicated the stock would fall from Monday's close.
" Shibutani said uncertainty remains for how the market will evolve in a Covid-endemic scenario. But he said the diversity within Pfizer's pipeline bolsters optimism that the company can perform even if it has a Covid trough. Outside its the company's Covid offerings, Shibutani sees potential in its late-stage growth offerings including the RSV vaccine, Nurtec for migraines and Oxbryta within the sickle cell space.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Protecting yourself against COVID-19 during the holidays - New York Amsterdam NewsAs we approach the third anniversary of the beginning of the COVID-19 pandemic, we are faced with COVID fatigue, conflicting information and the false idea that the pandemic is now over. So with the third holiday season of the COVID-19 pandemic in full swing, there are many lingering questions regarding COVID safety. Do I still […]
Read more »
Goldman Sachs Explains How to Regulate Crypto After FTXGoldman Sachs believes regulators should focus on crypto’s trusted, centralized entities – but not the blockchain.
Read more »
Goldman Sachs buying crypto firms, FTX news, 3AC and Celsius updates: Hodler’s Digest Dec. 4-10Musk also thinks that crypto assets will find their place as a check on central banks and global monetary policies in the long run. Catch up on more memorable quotes from last week in our Hodler’s Digest:
Read more »
Goldman Sachs Is Trying to Make Blockchain Bonds HappenBonds, bananas, tomatoes? Doesn’t matter, if they’re on your private, permissioned blockchain then that blockchain is worse than useless. gckaloudis writes for Crypto Long & Short.
Read more »
Goldman Sachs upgrades Gap, says stock can rally nearly 30% despite challenges facing retailersThe upcoming year provides a rough backdrop for retail, according to Goldman Sachs. But Gap is a name the firm expects to do well.
Read more »